Last reviewed · How we verify

NCT07024186

Xenogenic Collagen Matrix vs. Connective Tissue Graft for Soft Tissue Augmentation Around Early Maxillary Implants

Completed NA Last updated 17 June 2025
What this trial tests

NA trial testing Xenogeneic Collagen Matrix in Alveolar Bone Loss in 20 participants. Completed in 20 February 2025.

Timeline
17 March 2022
Primary endpoint
8 November 2024
20 February 2025

Quick facts

Lead sponsorMinia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date17 March 2022
Primary completion8 November 2024
Estimated completion20 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 25 to 55, any sex, with Alveolar Bone Loss or Gingival Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares two methods used to improve gingival tissue around dental implants placed in (the maxillary esthetic zone). After a tooth is removed and a dental implant is placed early (usually 4-8 weeks later), additional soft tissue is sometimes needed to ensure the implant looks natural and functions well. The two techniques being studied are: Subepithelial connective tissue graft (SCTG) - where tissue is taken from the patient's own mouth (usually the palate) Xenogeneic collagen matrix (XCM) - a processed collagen material from animals, used as a substitute for the patient's own tissue. The goal is to see which method is better in terms of gingival thickness, esthetic appearance, healing, and patient comfort. This research may help dentists choose the most effective and comfortable treatment for their patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07024186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing